One of the WORLD LEADERS in
BLOOD CANCER BREAKTHROUGHS

Top 10 in the US and BEST in the Rocky Mountain Region
for Stem Cell Transplant Outcomes

INNOVATIVE AND COMPASSIONATE CARE.

Treatments We Offer

Headlines - Good News

2024 By The Numbers....coming soon!

2023 By The Numbers

image reads

Upcoming Continuing Education Events

Updates in Hodgkin Lymphoma with Steve Bair, MD

Jan 14, 2025 | 03:30 PM - 04:30 PM

Add event to:

Registration Information

Predicting Venetoclax Responses in AML: How To Guide and Why it Matters with Dan Pollyea, MD, MS

Jan 21, 2025 | 03:30 PM - 04:30 PM

Add event to:

Registration Information

Leukemia

Jan 28, 2025 | 12:00 PM - 01:00 PM

Add event to:

The Clonal Hematopoiesis Clock: Studying preleukemic transformation in forward engineered model of acute leukemia with Cailin Collins, MD, Phd

Jan 28, 2025 | 03:30 PM - 04:30 PM

Add event to:

Registration Information

Denver ASH Review

Feb 8, 2025 | 07:50 AM - 12:30 PM

Add event to:

Learn More Here

Lymphoma

Feb 11, 2025 | 12:00 PM - 01:00 PM

Add event to:

For appointments,

for referrals,

for consultations -

Contact us ~ start here.

Hematology (SOM)

CU Anschutz

Research Complex II

12700 East 19th Avenue

Mail Stop B170

Aurora, CO 80045

Appointments: 720-848-6400

Tools & Resources

CU Campuses

CU Anschutz Medical Campus

Division of Hematology

School of Medicine

One of the WORLD LEADERS in
BLOOD CANCER BREAKTHROUGHS

Top 10 in the US and BEST in the Rocky Mountain Region
for Stem Cell Transplant Outcomes

About Us

For Patients

Continuing Education

Hematology Clinical Trials

We aim to pave the future of cancer care through breakthrough research at our clinical trials unit.

INNOVATIVE AND COMPASSIONATE CARE.

Treatments We Offer

Headlines - Good News

2024 By The Numbers....coming soon!

2023 By The Numbers

Upcoming Continuing Education Events

Updates in Hodgkin Lymphoma with Steve Bair, MD

Predicting Venetoclax Responses in AML: How To Guide and Why it Matters with Dan Pollyea, MD, MS

Leukemia

The Clonal Hematopoiesis Clock: Studying preleukemic transformation in forward engineered model of acute leukemia with Cailin Collins, MD, Phd

Denver ASH Review

Lymphoma

For appointments,

for referrals,

for consultations -

Contact us ~ start here.

Hematology (SOM)

One of the WORLD LEADERS in BLOOD CANCER BREAKTHROUGHS

Top 10 in the US and BEST in the Rocky Mountain Regionfor Stem Cell Transplant Outcomes

About Us

For Patients

Continuing Education

Hematology Clinical TrialsWe aim to pave the future of cancer care through breakthrough research at our clinical trials unit.

INNOVATIVE AND COMPASSIONATE CARE.

Treatments We Offer

Headlines - Good News

2024 By The Numbers....coming soon!

2023 By The Numbers

Upcoming Continuing Education Events

Updates in Hodgkin Lymphoma with Steve Bair, MD

Predicting Venetoclax Responses in AML: How To Guide and Why it Matters with Dan Pollyea, MD, MS

Leukemia

The Clonal Hematopoiesis Clock: Studying preleukemic transformation in forward engineered model of acute leukemia with Cailin Collins, MD, Phd

Denver ASH Review

Lymphoma

For appointments,

for referrals,

for consultations -

Contact us ~ start here.

Hematology (SOM)

One of the WORLD LEADERS in
BLOOD CANCER BREAKTHROUGHS

Top 10 in the US and BEST in the Rocky Mountain Region
for Stem Cell Transplant Outcomes

Hematology Clinical Trials

We aim to pave the future of cancer care through breakthrough research at our clinical trials unit.